0001571049-17-005703.txt : 20170605 0001571049-17-005703.hdr.sgml : 20170605 20170605184148 ACCESSION NUMBER: 0001571049-17-005703 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170605 DATE AS OF CHANGE: 20170605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dagger Thomas G CENTRAL INDEX KEY: 0001601340 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 17892597 MAIL ADDRESS: STREET 1: 41 WILCOX DRIVE CITY: MOUNTAIN LAKES STATE: NJ ZIP: 07046 FORMER NAME: FORMER CONFORMED NAME: Dagger Thomas Golden DATE OF NAME CHANGE: 20140404 FORMER NAME: FORMER CONFORMED NAME: Dagger THomas Golden DATE OF NAME CHANGE: 20140227 4 1 t1704006_f4-dagger.xml OWNERSHIP DOCUMENT X0306 4 2017-06-01 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001601340 Dagger Thomas G 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666-6712 0 1 0 0 SVP, Gen Counsel & Corp Secy Class A Common Stock 2017-06-01 4 M 0 1150 11.83 A 1150 D Class A Common Stock 2017-06-01 4 M 0 11050 11.83 A 12200 D Class A Common Stock 2017-06-01 4 S 0 12200 35.76 D 0 D Option to purchase Class A Common Stock 11.83 2017-06-01 4 M 0 1150 0 D 2013-03-01 2019-02-28 Class A Common Stock 1150 0 D Option to purchase Class A Common Stock 11.83 2017-06-01 4 M 0 11050 0 D 2014-03-01 2019-02-28 Class A Common Stock 11050 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $36.38. /s/ Thomas G. Dagger 2017-06-05